Applied BioCode (TPE:6598) Quick Ratio: 5.55 (As of Dec. 2025) — 21% Below Median


TPE:6598 Applied BioCode Corp TPE:6598
74 GF Score
Price NT$22.85
GF Value NT$23.33
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Applied BioCode Quick Ratio?

Applied BioCode TPE:6598 +0.22% 74 Quick Ratio is 5.55 as of Dec. 2025, which is 21% below its 10-year median of 7.02. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$23.33 (Fairly Valued). The stock has 6 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Applied BioCode ranks better than 85.36% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Applied BioCode's quick ratio for the quarter that ended in Dec. 2025 was 5.55.

Applied BioCode has a quick ratio of 5.55. It generally indicates good short-term financial strength.

The historical rank and industry rank for Applied BioCode's Quick Ratio or its related term are showing as below:

TPE:6598' s Quick Ratio Range Over the Past 10 Years
Min: 4.08   Med: 7.02   Max: 12.1
Current: 5.55

During the past 13 years, Applied BioCode's highest Quick Ratio was 12.10. The lowest was 4.08. And the median was 7.02.

TPE:6598's Quick Ratio is ranked better than
85.36% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs TPE:6598: 5.55

Applied BioCode  (TPE:6598) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Applied BioCode Quick Ratio Related Terms


Applied BioCode Quick Ratio Historical Data

* Premium members only.

The historical data trend for Applied BioCode's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied BioCode Quick Ratio Chart

Applied BioCode Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.10 10.36 6.52 7.04 5.55

Applied BioCode Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.04 7.55 7.71 6.41 5.55

TPE:6598 vs ABT, SYK, MDT: Quick Ratio Comparison

For the Medical Devices subindustry, Applied BioCode's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied BioCode Quick Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Applied BioCode's Quick Ratio falls into.


TPE:6598
74GF Score
Applied BioCode Corp TPE:6598
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied BioCode Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Applied BioCode's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(858.461-156.294)/126.546
=5.55

Applied BioCode's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(858.461-156.294)/126.546
=5.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 5.55 mean?
Applied BioCode (TPE:6598) has a Quick Ratio of 5.55 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Applied BioCode and its competitors. This is 21% below median its historical median of 7.02. Over the past decade, Applied BioCode's Quick Ratio has ranged from 4.08 to 12.10. According to the industry distribution chart, Applied BioCode ranks #125 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 14.6%.
Is Applied BioCode's Quick Ratio too high?
Applied BioCode's current Quick Ratio of 5.55 is 21% below median its 10-year median of 7.02. Over the past 10 years, this metric has ranged from a low of 4.08 to a high of 12.10. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Applied BioCode's value of 5.55 is 197.6% above this industry median. Based on the distribution chart, Applied BioCode ranks #125 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Applied BioCode ranks #125 out of 854 companies for Quick Ratio. This places Applied BioCode in the top 15% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.87. Applied BioCode's value of 5.55 is 197.6% above this benchmark. Historically, Applied BioCode's own Quick Ratio has ranged from 4.08 to 12.10 over the past decade. While the company's 10-year median is 7.02 vs. the industry median of 1.87, Applied BioCode has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Applied BioCode's current Quick Ratio of 5.55 is 197.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Applied BioCode and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Applied BioCode's current Quick Ratio is 5.55, which is 21% below median its own 10-year median of 7.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Fairly Valued. The stock's GF Value™ is NT$23.33, compared to a current price of NT$22.85 — trading 2.1% below its estimated fair value. The current Quick Ratio is 5.55, which is 21% below median its 10-year median of 7.02 and 197.6% above the Medical Devices & Instruments industry median of 1.87. Applied BioCode's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current Quick Ratio is 5.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be undervalued. The current stock price of NT$22.85 is trading 2.1% below its estimated GF Value™ of NT$23.33. GuruFocus considers Applied BioCode to be Fairly Valued.

Key valuation signals for TPE:6598:

  • Quick Ratio: 5.55 (21% below median its 10-year median of 7.02)
  • GF Value™: NT$23.33 vs. price of NT$22.85 (2.1% below fair value)
  • GF Score™: 74/100 with 6 warning signs
  • Industry Position: 197.6% above the Medical Devices & Instruments median (#125 of 854)

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Applied BioCode Business Description

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score

Get the complete analysis for TPE:6598

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.85
Price
NT$23.33
GF Value